Effect of Secretory Leukocyte Protease Inhibitor (SLPI) on β‐catenin localisation in breast cancer cells. Immunofluorescence images show cytoplasmic/nuclear localisation of β‐catenin in F3II mouse breast cancer cells transfected with SLPI (right). Typical membrane localisation is depicted in control cells (left) transfected with empty plasmid (F3II‐pcDNA3). When β‐catenin was localised in the cytoplasm/nuclear compartments of breast cancer cells, apoptosis‐related events were observed.
📖 افتح في inklap 🔗 DOI 📮 اطلب بحثاً